NELARABINE (has an active metabolite) | NELARABINE | ATC L01BB07
ANTINEOPLASTIC PRODRUG TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND T-CELL LYMPHOBLASTIC LYMPHOMA | INTRAVENOUS | Cmax 16.8 MICROMOLAR VD 318.5 LITER PPB 25 PERCENT Cl 315 LITER / HOUR HT 0.3 HOUR SOLUBILITY SLIGHTLY SOLUBLE TO SOLUBLE IN WATER | ADENOSINE DEAMINASE | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |